Stay updated on MK-3475+Laser+Ablation in Gliomas Clinical Trial
Sign up to get notified when there's something new on the MK-3475+Laser+Ablation in Gliomas Clinical Trial page.

Latest updates to the MK-3475+Laser+Ablation in Gliomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record for the trial of pembrolizumab with MRI-guided laser ablation is displayed, including its completed status, eligibility criteria, treatment plan, outcome measures, and results-related information.SummaryDifference63%

- Check18 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now returns a 403 error, replacing the prior study details with a 403 page. As a result, users cannot view the study information or related resources.SummaryDifference21%

Stay in the know with updates to MK-3475+Laser+Ablation in Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475+Laser+Ablation in Gliomas Clinical Trial page.